SUNRIDGE MEDICAL • SCOTTSDALE, ARIZONA
Alternative Lung Cancer Treatment & Integrative Lung Cancer Care in Scottsdale, Arizona
People searching for alternative lung cancer treatment are often looking for a broader, physician-directed strategy that examines both the cancer and the biological environment surrounding it.
At Sunridge Medical in Scottsdale, Arizona, we develop individualized integrative oncology programs for patients with non-small cell lung cancer, small cell lung cancer, recurrent disease and metastatic lung cancer.
Our approach may incorporate physician-directed intravenous therapies, high-dose IV vitamin C, botanical medicine, mistletoe, metabolic strategies, oxidative therapies, nutritional medicine and other individualized treatments selected around the patient’s diagnosis, laboratory findings, medications, organ function and current oncology plan.
The objective is to build a treatment strategy around the individual patient—not simply around the name of the cancer.
UNDERSTANDING THE CANCER
Lung Cancer Is Not One Disease
Lung cancer includes several biologically distinct diseases. The two major categories are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC includes adenocarcinoma, squamous cell carcinoma and other subtypes.
Modern treatment increasingly depends upon stage, pathology and molecular characteristics. NCI lists surgery, chemotherapy, radiation, targeted therapy and immunotherapy among the major treatment categories for NSCLC.1
For advanced NSCLC, molecular findings can materially change treatment decisions, which is why pathology and genomic results deserve close review before an integrative plan is built.
PERSONALIZED REVIEW
A More Individualized Approach to Alternative Lung Cancer Treatment
An effective alternative lung cancer treatment program starts with a detailed review of the case.
Depending on the patient, our physicians may review:
- Pathology and cancer subtype
- Stage and sites of disease
- PET/CT, CT, MRI and other imaging
- Molecular and genomic testing
- Current and previous chemotherapy, radiation, immunotherapy or targeted therapy
- Treatment response and progression pattern
- Blood counts and organ function
- Inflammatory and metabolic markers
- Nutritional deficiencies
- Current medications and potential treatment interactions
This information helps determine which physician-directed integrative therapies may be appropriate and how they should be timed around the patient’s broader oncology plan.
PHYSICIAN-DIRECTED IV THERAPY
Intravenous Therapies in Integrative Lung Cancer Care
Intravenous therapies are commonly used in integrative oncology because they allow selected compounds to enter the circulation directly and, in some cases, achieve concentrations that are not possible through oral dosing.
At Sunridge Medical, IV therapies are individualized according to the patient’s diagnosis, laboratory values, kidney and liver function, medications and current cancer treatment.
Depending upon the case, IV treatment may be used as part of a broader strategy addressing oxidative balance, nutritional status, cellular metabolism, treatment recovery and overall physiologic resilience.
RESEARCH-BASED INTEGRATIVE THERAPY
High-Dose Intravenous Vitamin C
High-dose intravenous vitamin C is one of the most researched physician-directed therapies in integrative oncology. Intravenous administration produces blood concentrations that cannot ordinarily be achieved through oral vitamin C.
The National Cancer Institute maintains a dedicated evidence review of intravenous vitamin C in cancer care and notes that clinical studies have examined its safety, quality-of-life effects and use with standard therapies.2
In lung cancer specifically, a randomized phase II study evaluated intravenous vitamin C combined with modulated electrohyperthermia in previously treated advanced NSCLC.3
At Sunridge Medical, IV vitamin C may be considered within an individualized natural lung cancer treatment program when clinically appropriate. Kidney function, laboratory testing, medications and the patient’s concurrent oncology treatment are reviewed before use.
ADVANCED INTEGRATIVE STRATEGIES
Hyperthermia, Oxidative Therapies and Cancer Metabolism
Cancer cells can differ from healthy cells in metabolism, mitochondrial function, redox regulation and stress-response pathways. These differences have created ongoing interest in therapies that alter the tumor environment or increase cellular stress.
Physician-directed approaches may include regional hyperthermia or electrohyperthermia and selected oxidative therapies when appropriate for the individual patient.
The randomized phase II NSCLC study cited above is particularly relevant because it examined a combined integrative strategy using IV vitamin C and modulated electrohyperthermia in advanced lung cancer rather than evaluating a general wellness intervention.3
These therapies are not selected by diagnosis alone. Disease burden, cardiopulmonary status, prior treatment, organ function and the patient’s current oncology plan all influence whether they are reasonable to consider.
BOTANICAL & NATURAL MEDICINE
Botanical Medicine and Natural Compounds
Botanical medicine is an important part of naturopathic oncology. Plant-derived compounds can affect inflammatory signaling, oxidative stress, immune activity, cellular signaling and metabolism.
Depending upon the patient, a physician-directed program may consider compounds such as curcumin, green-tea constituents, medicinal mushrooms, mistletoe and other concentrated botanical extracts.
The emphasis is on selecting compounds for a defined clinical purpose and evaluating them in the context of the patient’s medications, treatment schedule and organ function.
The National Cancer Institute maintains evidence summaries for multiple integrative and complementary cancer therapies, including IV vitamin C and other biologically based approaches.4
MISTLETOE THERAPY
Mistletoe in Integrative Lung Cancer Care
Mistletoe extracts have been used in European integrative oncology for decades and have been studied as an adjunct to conventional cancer therapy.
A randomized phase II study in patients with advanced non-small cell lung cancer treated with carboplatin-based chemotherapy evaluated complementary mistletoe therapy. Overall survival was similar between the groups, while some chemotherapy-related outcomes differed; the authors concluded that further study was warranted.5
At Sunridge Medical, mistletoe may be considered as one component of a broader physician-directed integrative lung cancer treatment plan. It is not treated as a universal protocol.
IMMUNE-FOCUSED CARE
The Immune Environment and Lung Cancer
The success of checkpoint inhibitors in lung cancer demonstrates the importance of immune signaling in tumor control. NCI includes immunotherapy among current treatment options for many patients with NSCLC.1
For patients receiving immunotherapy, integrative treatment must be selected carefully because checkpoint inhibitors intentionally alter immune regulation.
Our physicians may review inflammatory patterns, nutritional deficiencies, autoimmune history, organ function and treatment-related immune effects before selecting natural or intravenous therapies.
The objective is not to apply a generic “immune boosting” protocol. It is to understand the patient’s immune environment and coordinate integrative care around the biology of the therapy already being used.
PRECISION ONCOLOGY
Molecular Testing Can Change the Treatment Strategy
Comprehensive molecular testing can be especially important in advanced non-small cell lung cancer.
Depending upon histology and clinical circumstances, testing may identify alterations involving genes such as EGFR, ALK, ROS1, KRAS, BRAF, MET, RET, NTRK and HER2. These findings can open the door to targeted treatments and can substantially change the overall treatment plan.1
For a patient seeking alternative lung cancer treatment, these results are still highly relevant. A serious integrative plan should be built with the best available understanding of the tumor’s molecular biology.
COORDINATED INTEGRATIVE CARE
Integrative Care During Chemotherapy, Radiation and Immunotherapy
Many Sunridge Medical patients continue conventional oncology treatment while receiving physician-directed integrative care.
The integrative plan may be coordinated around chemotherapy cycles, radiation schedules, immunotherapy infusions or targeted medications. Laboratory monitoring, kidney and liver function, blood counts, treatment toxicities and medication interactions can all influence what is used and when.
For patients receiving checkpoint inhibitors, particular attention may be paid to immune-mediated changes involving the thyroid, lungs, liver, gastrointestinal tract, skin and other organs.
The purpose is to create a coordinated treatment strategy rather than layering therapies together without considering timing or biological interaction.
ADVANCED & METASTATIC DISEASE
Alternative Lung Cancer Treatment for Stage IV Disease
A significant number of patients who contact Sunridge Medical have Stage IV or metastatic lung cancer.
Some are newly diagnosed. Others have already received chemotherapy, radiation, immunotherapy, targeted therapy or multiple lines of treatment.
In advanced disease, we may reassess pathology, molecular testing, treatment history, progression pattern, organ function, disease burden and the patient’s current physiologic reserve.
An individualized Stage IV lung cancer treatment program may then incorporate physician-directed IV therapies, botanical medicine, mistletoe, hyperthermia, metabolic strategies, oxidative therapies and other integrative approaches selected according to the patient’s clinical circumstances.
WHEN PREVIOUS TREATMENT HAS STOPPED WORKING
Re-Evaluating Lung Cancer After Progression
Cancer biology can change over time. When lung cancer progresses despite treatment, it may be useful to review the case again rather than assume that every avenue has been exhausted.
Questions may include:
- Has comprehensive molecular testing been performed?
- Could repeat biopsy or liquid biopsy provide additional information?
- Has the molecular profile changed?
- Are there additional targeted therapies or clinical trials?
- Could localized treatment be useful for selected sites of disease?
- Which integrative therapies remain appropriate based on current organ function and treatment tolerance?
The integrative plan should evolve as the cancer and the patient change.
THE SUNRIDGE APPROACH
Why Patients Choose Sunridge Medical for Integrative Lung Cancer Care
Sunridge Medical focuses on complex cancer cases and individualized integrative oncology.
A treatment program may combine:
- Integrative and naturopathic oncology
- High-dose IV vitamin C
- Other physician-directed intravenous therapies
- Regional hyperthermia or electrohyperthermia when appropriate
- Botanical medicine
- Mistletoe therapy
- Oxidative therapies
- Metabolic medicine
- Nutritional medicine
- Laboratory monitoring
- Review of molecular and genomic testing
The combination varies from patient to patient. Personalization is central to the treatment strategy.
SCOTTSDALE • PHOENIX • ARIZONA
Alternative Lung Cancer Treatment in Scottsdale, Arizona
Sunridge Medical is located in Scottsdale, Arizona, serving patients from Scottsdale, Phoenix and communities throughout Arizona.
We also work with patients who travel from across the United States and internationally for integrative cancer care.
People searching for alternative lung cancer treatment in Arizona, natural lung cancer treatment, integrative lung cancer treatment, holistic lung cancer treatment or an integrative cancer center in Scottsdale often come to Sunridge because they are looking for a physician-directed approach that considers more than one treatment modality.
FREQUENTLY ASKED QUESTIONS
Frequently Asked Questions About Alternative Lung Cancer Treatment
What is alternative lung cancer treatment?
At Sunridge Medical, alternative and integrative lung cancer care can include physician-directed intravenous therapies, natural compounds, botanical medicine, mistletoe, hyperthermia, metabolic strategies and other individualized treatments selected according to the patient’s diagnosis and medical condition.
What is integrative lung cancer treatment?
Integrative lung cancer treatment combines physician-directed natural and complementary therapies with a careful understanding of the patient’s conventional oncology plan, pathology, laboratory findings and molecular testing.
Does Sunridge Medical work with Stage IV lung cancer?
Yes. Patients with advanced and metastatic cancers seek care at Sunridge Medical. Treatment selection depends upon cancer subtype, molecular findings, previous treatment, metastatic sites, organ function and overall clinical condition.
Does Sunridge Medical offer high-dose IV vitamin C?
High-dose intravenous vitamin C is among the physician-directed therapies that may be considered within an individualized integrative cancer program. NCI maintains a dedicated evidence review of IV vitamin C in cancer care.
Can integrative therapies be used during chemotherapy or immunotherapy?
They may be considered, but timing and selection require physician review because medications, organ function, blood counts, treatment toxicities and immune effects can alter what is appropriate.
Why is molecular testing important in lung cancer?
Some non-small cell lung cancers contain molecular alterations that can be treated with specific targeted medications. These findings can substantially change the overall treatment strategy.
Where is Sunridge Medical located?
Sunridge Medical is located in Scottsdale, Arizona, in the Phoenix metropolitan area, and works with local, national and international cancer patients.
BECOME A PATIENT
Explore a More Comprehensive Approach to Lung Cancer
A lung cancer diagnosis can involve complex decisions involving pathology, molecular testing, systemic therapy, radiation, immune treatment and supportive care.
At Sunridge Medical, we bring those clinical details together with physician-directed natural and integrative therapies to create an individualized plan.
Call our Patient Care Team to discuss your diagnosis, previous treatment and goals.
Hear From Our Patients.
SOURCES
References
- National Cancer Institute. Non-Small Cell Lung Cancer Treatment (PDQ®) – Health Professional Version. Treatment overview including surgery, chemotherapy, radiation, targeted therapy and immunotherapy.
- National Cancer Institute. Intravenous Vitamin C (PDQ®) – Health Professional Version. Evidence review of pharmacologic IV vitamin C in cancer care.
- Ou J, et al. A randomized phase II trial of best supportive care with or without modulated electrohyperthermia and intravenous vitamin C for previously treated advanced non-small-cell lung cancer. European Journal of Cancer. 2020. PMID: 32368355.
- National Cancer Institute. PDQ® Integrative, Alternative, and Complementary Therapies Summaries. NCI evidence summaries for integrative cancer therapies.
- Bar-Sela G, Wollner M, Hammer L, Agbarya A, Dudnik E, Haim N. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomized phase II study. European Journal of Cancer. 2013;49(5):1058-1064. PMID: 23218588.
- National Cancer Institute. Immunotherapy to Treat Cancer. Overview of immune-directed cancer treatment.
